Armata Pharmaceuticals, Inc.
ARMP
$2.68
$0.2510.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.30M | -6.53M | 2.60M | -5.48M | 8.99M |
| Total Depreciation and Amortization | 366.00K | 377.00K | 380.00K | 313.00K | 315.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.71M | -229.00K | -12.10M | -2.76M | -18.82M |
| Change in Net Operating Assets | -2.00M | -1.20M | 1.19M | -935.00K | -661.00K |
| Cash from Operations | -7.21M | -7.58M | -7.93M | -8.86M | -10.18M |
| Capital Expenditure | -149.00K | -99.00K | 77.00K | -340.00K | -1.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -149.00K | -99.00K | 77.00K | -340.00K | -1.37M |
| Total Debt Issued | 0.00 | 10.00M | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 88.00K |
| Repurchase of Common Stock | 0.00 | -14.00K | 0.00 | -61.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 9.99M | 0.00 | -61.00K | 88.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.36M | 2.31M | -7.85M | -9.26M | -11.46M |